Table 2 Comparison of tumor infiltrating lymphocytes (TILs) and CD8-positive TILs grades in primary tumors between the pCR and non-pCR groups.

From: Prognostic utility of tumor-infiltrating lymphocytes in residual tumor after neoadjuvant chemotherapy with trastuzumab for HER2-positive breast cancer

Factors

pCR group

Non-pCR group

pCR ratio

N

N

%

TILs

Low

36

30

54.5

Intermediate

27

11

71.1

High

20

4

83.3

CD8-positve TILs

Low

17

13

56.7

High

61

26

70.1

Total

83

45

64.8

  1. Abbreviations: TILs, tumor infiltrating lymphocytes; pCR, pathological complete response.
Back to article page